Market Access/ News/ News/ R&D/ Top stories/ UK & Europe Sanofi says biotech acquisitions will help overcome diabetes decline Andrew McConaghie Ablynx, Bioverativ, haeomophilia, Sanofi 0 Comment Sanofi has just spent $16 billion on acquiring Bioverativ and Ablynx – and yesterday’s Q4 results revealed why Share X Sanofi says biotech acquisitions will help overcome diabetes decline https://pharmaphorum.com/news/sanofi-says-biotech-acquisitions-will-help-overcome-diabetes-decline/
